Mevion is establishing a JV in China with HOPU Investments and YuanMing Capital up to 200 million dollars.

In addition to forming the joint venture, HOPU and YuanMing, along with other Chinese investors and Mevion's existing U.S. investors, entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate our worldwide expansion. The investment will support an increase in our manufacturing capacity and global service capability to support the installation of new proton therapy sites in the U.S., China and internationally.

ask about product: Mevion is establishing a JV in China with HOPU Investments and YuanMing Capital up to 200 million dollars.